| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net income | 2,555 | 1,643 | 583 | 2,330 |
| Depreciation, amortization and accretion, net | -73 | -54 | -27 | -125 |
| Deferred income tax expense (benefit) | 187 | 107 | -95 | 169 |
| Share-based compensation | 145 | 95 | 49 | 138 |
| Net realized investment (gains) losses | 1 | -10 | 5 | 0 |
| Net trading (gains) losses | 4 | 2 | 1 | 5 |
| Loss from equity method investments | -3 | -9 | -13 | -13 |
| Impairments and provision for loan and credit losses | 7 | -4 | -5 | 5 |
| Net (gains) losses of consolidated investment entities | -4 | -7 | -12 | -5 |
| Restricted and segregated investments | -477 | -477 | -158 | 2 |
| Deferred acquisition costs | -43 | -30 | -16 | -27 |
| Policyholder account balances, future policy benefits and claims, and market risk benefits, net | 3,781 | 2,178 | 940 | 3,445 |
| Derivatives, net of collateral | -847 | -275 | 270 | -1,168 |
| Receivables | 451 | 103 | 220 | -221 |
| Brokerage deposits | -215 | -146 | -25 | 245 |
| Accounts payable and accrued expenses | -27 | -273 | -452 | -27 |
| Current income tax, net | -276 | -413 | 180 | 174 |
| Other operating assets and liabilities of consolidated investment entities, net | -5 | -7 | -2 | -1 |
| Other, net | -341 | -157 | -293 | -766 |
| Net cash provided by (used in) operating activities | 5,654 | 3,450 | 1,686 | 6,212 |
| Proceeds from sales | 1,901 | 1,573 | 1,075 | 1,810 |
| Maturities, sinking fund payments and calls | 13,034 | 8,483 | 4,221 | 11,136 |
| Purchases | 14,298 | 10,642 | 6,834 | 12,626 |
| Proceeds from sales, maturities and repayments of mortgage loans | 153 | 86 | 37 | 128 |
| Funding of mortgage loans | 450 | 240 | 107 | 309 |
| Proceeds from sales, maturities and collections of other investments | 61 | 51 | 22 | 102 |
| Purchase of other investments | 47 | 41 | 26 | 153 |
| Purchase of investments by consolidated investment entities | 1,064 | 731 | 354 | 791 |
| Proceeds from sales, maturities and repayments of investments by consolidated investment entities | 663 | 426 | 167 | 700 |
| Purchase of land, buildings, equipment and software | 118 | 74 | 36 | 118 |
| Cash paid for written options with deferred premiums | 0 | 0 | 0 | 57 |
| Cash received from written options with deferred premiums | 5 | 5 | 0 | 22 |
| Cash paid for deposit receivables | 22 | 15 | 8 | 25 |
| Cash received for deposit receivables | 330 | 229 | 112 | 470 |
| Other, net | 83 | 49 | 10 | 57 |
| Net cash provided by (used in) investing activities | 65 | -939 | -1,741 | 232 |
| Proceeds from additions | 2,447 | 1,752 | 961 | 3,883 |
| Maturities, withdrawals and cash surrenders | 4,707 | 3,055 | 1,471 | 5,353 |
| Deposits and other additions | 967 | 590 | 254 | 1,094 |
| Net transfers from (to) separate accounts | -118 | -71 | -36 | -124 |
| Surrenders and other benefits | 1,110 | 751 | 395 | 1,385 |
| Change in banking deposits, net | 286 | 191 | 363 | 233 |
| Cash paid for purchased options with deferred premiums | 71 | 40 | 3 | 122 |
| Cash received for purchased options with deferred premiums | 46 | 0 | 0 | 181 |
| Issuance of long-term debt, net of issuance costs | 740 | 740 | 740 | 0 |
| Repayments of long-term debt | 508 | 506 | 3 | 8 |
| Dividends paid to shareholders | 447 | 296 | 144 | 430 |
| Repurchase of common shares | 2,012 | 1,311 | 730 | 1,783 |
| Borrowings of consolidated investment entities | 817 | 691 | 304 | 883 |
| Repayments of debt by consolidated investment entities | 618 | 362 | 328 | 778 |
| Other, net | 2 | - | - | 2 |
| Net cash provided by (used in) financing activities | -4,286 | -2,428 | -488 | -3,707 |
| Effect of exchange rate changes on cash | 30 | 38 | 13 | 22 |
| Net increase (decrease) in cash and cash equivalents, including amounts restricted | 1,463 | 121 | -530 | 2,759 |
| Cash and cash equivalents at beginning of period | 9,489 | 9,489 | 9,489 | 8,620 |
| Cash and cash equivalents at end of period | 10,952 | 9,610 | 8,959 | 11,379 |
AMERIPRISE FINANCIAL INC (AMP)
AMERIPRISE FINANCIAL INC (AMP)